3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
10
Colorectal Neoplasms
9
Rectal Neoplasms
8
Wilms Tumor
7
Pancreatic Neoplasms
7
Neuroblastoma
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Glioma
7
Sarcoma
6
Rhabdomyosarcoma
6
Rhabdoid Tumor
6
Osteosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Lung Neoplasms
5
Central Nervous System Neoplasms
5
Stomach Neoplasms
4
Sarcoma, Ewing
4
Ovarian Neoplasms
4
Esophageal Neoplasms
4
Colonic Neoplasms
4
Melanoma
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Prostatic Neoplasms
2
Lymphoma
2
Liver Neoplasms
2
Interventions
belinostat
2
sodium thiosulfate
1
sargramostim
1
romidepsin
1
pembrolizumab
1
enzalutamide
1
brostallicin
1
X-Rays
1
Trabectedin
1
Therapeutics
1
Sunitinib
1
Specimen Handling
1
Radiation, Ionizing
1
Quality of Life
1
Platinum
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Midazolam
1
Magnetic Resonance Spectroscopy
1
Letrozole
1
Immunotherapy
1
Imatinib Mesylate
1
Hyperthermic Intraperitoneal Chemotherapy
1
Histamine H2 Antagonists
1
HhAntag691
1
Fulvestrant
1
Fluorouracil
1
Famotidine
1
Drug Therapy
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liposarcoma
×
X-Rays
×
Gastrointestinal
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled